Literature DB >> 6940684

Radioimmunoassay for serum and urinary lysozyme.

M J Thomas, A Russo, P Craswell, M Ward, I Steinhardt.   

Abstract

We describe a radioimmunoassay for lysozyme (EC 3.2.1.17, mucopeptide N-acetylmuramohydrolase) in plasma and urine. It involves use of an antibody, raised in rabbits, to lysozyme from urine from a patient with monocytic leukemia. This antiserum, diluted 4000-fold, is incubated with radiolabeled lysozyme for 2 h and antibody-bound lysozyme is separated from free lysozyme with dextran-coated charcoal. Validation of the assay included precision and parallelism studies with serum and urine samples from patients with monocytic leukemia and analgesic nephropathy. Results of the radioimmunoassay and those obtained with a Micrococcus lysodeikticus lytic assay correlated well (r = 0.94). Sensitivity of the assay was 3.5 micrograms/L for both serum and urine. The main advantages of the assay are its good precision and reproducibility and its high sensitivity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6940684

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Development of a microparticle-enhanced nephelometric immunoassay for quantitation of human lysozyme in pleural effusion and plasma.

Authors:  M Caballero; R Ruiz; M Márquez de Prado; M Seco; L Borque; J F Escanero
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  What's new in lysozyme research? Always a model system, today as yesterday.

Authors:  P Jollès; J Jollès
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

3.  Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin.

Authors:  J E Hopper; W Sequeira; J Martellotto; E Papagiannes; L Perna; J L Skosey
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.